Meeder Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,949
Closed -$175K 1560
2021
Q3
$175K Sell
2,949
-279
-9% -$21.9K 0.01% 762
2021
Q2
$280K Buy
3,228
+330
+11% +$26.6K 0.01% 654
2021
Q1
$239K Buy
+2,898
New +$278K 0.01% 684
2020
Q4
Sell
-2,133
Closed -$84K 1986
2020
Q3
$84K Sell
2,133
-3,101
-59% -$108K 0.01% 829
2020
Q2
$180K Buy
5,234
+662
+14% +$19.7K 0.01% 623
2020
Q1
$101K Buy
4,572
+2,543
+125% +$64.3K 0.01% 713
2019
Q4
$39K Buy
2,029
+640
+46% +$10.2K ﹤0.01% 1102
2019
Q3
$21K Sell
1,389
-8,719
-86% -$167K ﹤0.01% 1290
2019
Q2
$205K Buy
10,108
+7,282
+258% +$131K 0.01% 572
2019
Q1
$50K Buy
2,826
+2,015
+248% +$31.8K ﹤0.01% 880
2018
Q4
$10K Buy
811
+178
+28% +$2.48K ﹤0.01% 1243
2018
Q3
$10K Sell
633
-1,953
-76% -$23.1K ﹤0.01% 1159
2018
Q2
$29.3K Buy
2,586
+1,452
+128% +$16K ﹤0.01% 884
2018
Q1
$12K Buy
1,134
+917
+423% +$8.79K ﹤0.01% 1018
2017
Q4
$1K Buy
+217
New +$968 ﹤0.01% 1564

Other funds holding FATE